Mannitol Dose Calculation for 20% Solution
For reducing intracranial pressure or brain mass, administer 0.25 to 2 g/kg of body weight as a 20% mannitol solution (250 mg/mL) infused over 30-60 minutes, with the optimal dose being 1.0 g/kg for most adult patients. 1
Standard Dosing by Patient Population
Adults
- Standard dose: 1.0 g/kg body weight 1, 2
- Range: 0.25 to 2 g/kg depending on clinical severity 1
- Small or debilitated patients: 500 mg/kg 1
Pediatric Patients
Volume Calculation Formula
Since 20% mannitol = 250 mg/mL = 0.25 g/mL:
Volume (mL) = [Dose (g/kg) × Weight (kg)] ÷ 0.25 g/mL
Practical Examples:
- 70 kg adult at 1.0 g/kg: (1.0 × 70) ÷ 0.25 = 280 mL
- 70 kg adult at 0.5 g/kg: (0.5 × 70) ÷ 0.25 = 140 mL
- 100 kg adult at 1.0 g/kg: (1.0 × 100) ÷ 0.25 = 400 mL
Administration Parameters
Infusion Rate
- Duration: 15-20 minutes for acute ICP crisis 3, or 30-60 minutes for standard use 1
- Osmotic load: Each dose delivers approximately 250 mOsm 3
Timing Considerations
Research demonstrates that starting mannitol 60-70 minutes before dural opening (rather than at skin incision) provides superior brain relaxation and lower ICP in neurosurgical cases 4. For emergency ICP management, administer immediately.
Dose Selection Algorithm
1.0 g/kg is the evidence-based optimal dose that balances efficacy with safety 2. This dose provides:
- 67.7% satisfactory brain relaxation rate
- Acceptable adverse effect profile
- Predictable osmotic effect
Higher doses (1.5 g/kg) offer minimal additional benefit but significantly increase risks:
- 38.7% incidence of moderate hyponatremia
- Hyperkalemia in 12.9% of patients 2
Lower doses (0.25-0.5 g/kg) show reduced efficacy:
- Only 32.2% satisfactory brain relaxation at 0.25 g/kg 2
Critical Monitoring Requirements
Before Administration
- Verify adequate renal function (contraindicated in established anuria) 1
- Assess volume status (contraindicated in severe dehydration) 1
- Check for pulmonary edema (absolute contraindication) 1
During/After Administration
- Serum osmolality: Target increase of approximately 10-20 mOsm/kg 2
- Electrolytes: Monitor sodium (risk of hypo/hypernatremia) and potassium 1
- Fluid balance: Expect osmotic diuresis; replace losses appropriately 3
- Cardiovascular status: Watch for volume overload in at-risk patients 1
Important Caveats
Obesity consideration: Current weight-based dosing produces higher-than-expected plasma concentrations in obese patients 5. Consider using ideal body weight or lower end of dosing range.
Repeat dosing: Administer at 4-6 hour intervals if needed 6. The ICP-lowering effect lasts 2-4 hours 3.
Hypertonic saline alternative: At equiosmolar doses (250 mOsm), hypertonic saline may be more effective than mannitol for refractory ICP elevation 6, 3, 7, though mannitol remains first-line in most protocols.
Avoid nephrotoxic drugs: Do not combine with other diuretics or nephrotoxic agents due to increased renal failure risk 1.